ArticleAnnals of translational medicine2021

Apatinib enhances the anti-tumor effect of paclitaxel via the PI3K/p65/Bcl-xl pathway in triple-negative breast cancer.

Jing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.